Psychosocial and cognitive function in children with nephrotic syndrome

dc.contributor.author	Μάντη, Παναγιώτα	el
dc.contributor.author	Γιαννακόπουλος, Γιώργος	el
dc.contributor.author	Γιουρούκου, Έλενα	el
dc.contributor.author	Γεωργάκη - Αγγελάκη, Ελένη	el
dc.contributor.author	Στεφανίδης, Κωνσταντίνος	el
dc.date.accessioned	2015-06-07T16:42:22Z
dc.date.available	2015-06-07T16:42:22Z
dc.date.issued	2015-06-07
dc.identifier.uri	http://hdl.handle.net/11400/15490
dc.rights	Αναφορά Δημιουργού-Μη Εμπορική Χρήση-Όχι Παράγωγα Έργα 3.0 Ηνωμένες Πολιτείες	*
dc.rights.uri	http://creativecommons.org/licenses/by-nc-nd/3.0/us/	*
dc.source	http://www.bpsmedicine.com	en
dc.subject	Children
dc.subject	Psychosocial atitude
dc.subject	Steroids
dc.subject	Παιδιά
dc.subject	Ψυχοκοινωνική συμπεριφορά
dc.subject	Στεροειδή
dc.title	Psychosocial and cognitive function in children with nephrotic syndrome	en
heal.type	journalArticle
heal.secondaryTitle	association with disease and treatment variables	en
heal.classification	Psychology
heal.classification	Mental health
heal.classification	Ψυχολογία
heal.classification	Ψυχική υγεία
heal.classificationURI	http://id.loc.gov/authorities/subjects/sh85108459
heal.classificationURI	http://id.loc.gov/authorities/subjects/sh00006455
heal.classificationURI	N/A-Ψυχολογία
heal.classificationURI	N/A-Ψυχική υγεία
heal.contributorName	Μητσιώνη, Ανδρομάχη	el
heal.contributorName	Στεργίου, Νίκος	el
heal.contributorName	Μίχας, Κωνσταντίνος	el
heal.contributorName	Χρουσός, Γιώργος	el
heal.contributorName	Μαγιακού, Μαρία	el
heal.contributorName	Κολαΐτης, Γεράσιμος	el
heal.identifier.secondary	DOI: 10.1186/1751-0759-7-10
heal.language	en
heal.access	campus
heal.publicationDate	2013
heal.bibliographicCitation	Manti, P., Giannakopoulos, G., Giouroukou, E., Georgaki-Angelaki, H., Stefanidis, C. et al. (2013) Psychosocial and cognitive function in children with nephrotic syndrome: Association with disease and treatment variables. "BioPsychoSocial Medicine", 7 (1)	en
heal.abstract	To investigate possible differences in emotional/behavioral problems and cognitive function in children with nephrotic syndrome compared to healthy controls and to examine the effect of disease-specific and steroid treatment-specific characteristics on the abovementioned variables.Methods: Forty-one patients with nephrotic syndrome (23 boys, age range: 4.4-15.2 years) and 42 sex- and age-matched healthy control subjects (20 boys, age range: 4.1-13.4 years) were enrolled in the study. Disease (severity, age of diagnosis, duration) and steroid treatment (total duration, present methylprednisolone dose and duration of present dose) data were collected. In order to assess children's emotional/behavioral problems, the Child Behavior Checklist was administered. The Wechsler Intelligence Scale for Children - Third Edition was administered to assess Full-Scale, Verbal, and Performance intelligence quotient (IQ) scores.Results: The patients presented with more internalizing problems (P = 0.015), including withdrawal (P = 0.012) and somatic complaints (P = 0 .011), but not more anxiety/depression or externalizing problems. A significant association was found between severity of disease and somatic complaints (P = 0.017) as well as externalizing problems (P = 0.030). Years of illness were significantly more in those presenting with abnormal anxiety/depression (P = 0.011). Duration of steroid medication was significantly higher among those presenting with abnormal anxiety/depression (P = 0.011) and externalizing problems (P = 0.039). IQ was not associated significantly with disease or steroid treatment variables.Conclusions: Psychosocial factors and outcomes may be important correlates of children's nephrotic syndrome and potential targets of thorough assessment and treatment.	en
heal.journalName	BioPsychoSocial Medicine	en
heal.journalType	peer-reviewed
heal.fullTextAvailability	true